Your browser doesn't support javascript.
loading
Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib.
Loehr, Andrea; Hussain, Arif; Patnaik, Akash; Bryce, Alan H; Castellano, Daniel; Font, Albert; Shapiro, Jeremy; Zhang, Jingsong; Sautois, Brieuc; Vogelzang, Nicholas J; Chatta, Gurkamal; Courtney, Kevin; Harzstark, Andrea; Ricci, Francesco; Despain, Darrin; Watkins, Simon; King, Charmin; Nguyen, Minh; Simmons, Andrew D; Chowdhury, Simon; Abida, Wassim.
Afiliación
  • Loehr A; Translational Medicine, Clovis Oncology, Inc, Boulder, CO, USA.
  • Hussain A; Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.
  • Patnaik A; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Bryce AH; Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Castellano D; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Font A; Medical Oncology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
  • Shapiro J; Medical Oncology, Cabrini Hospital, Malvern, VIC, Australia.
  • Zhang J; Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Sautois B; Medical Oncology, CHU Sart Tilman, University of Liège, Liège, Belgium.
  • Vogelzang NJ; Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA.
  • Chatta G; Medical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Courtney K; Hematology/Oncology, UT Southwestern Medical Center, Dallas, TX, USA.
  • Harzstark A; Hematology/Oncology, Kaiser Permanente Oncology Clinical Trials Program, San Francisco, CA, USA.
  • Ricci F; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.
  • Despain D; Biostatistics, Clovis Oncology, Inc., Boulder, CO, USA.
  • Watkins S; Clinical Development, Clovis Oncology UK Ltd, Cambridge, UK.
  • King C; Clinical Operations, Clovis Oncology, Inc, Boulder, CO, USA.
  • Nguyen M; Translational Medicine, Clovis Oncology, Inc, Boulder, CO, USA.
  • Simmons AD; Translational Medicine, Clovis Oncology, Inc, Boulder, CO, USA.
  • Chowdhury S; Medical Oncology, Guy's Hospital, London, UK; Sarah Cannon Research Institute, London, UK.
  • Abida W; Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: abidam@mskcc.org.
Eur Urol ; 83(3): 200-209, 2023 03.
Article en En | MEDLINE | ID: mdl-36243543
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Ácidos Nucleicos Libres de Células Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Eur Urol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Ácidos Nucleicos Libres de Células Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Eur Urol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos